Posts

Posted on

Align Technology Hosts 2026 Invisalign® Ortho Summit, Showcasing a “Beyond Possible” Vision for Connected Digital Orthodontics

Align Technology Hosts 2026 Invisalign® Ortho Summit, Showcasing a “Beyond Possible” Vision for Connected Digital Orthodontics

A multi-day, immersive experience in Las Vegas brought orthodontists and practice teams together for peer-led clinical education, hands-on innovation, and a look at how Align is redefining what’s possible with digital orthodontic care

LAS VEGAS & TEMPE, Ariz.–(BUSINESS WIRE)–
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from its 2026 Invisalign® Ortho Summit, held July 23–26, 2026 in Las Vegas.

The Summit brought together more than 500 orthodontists and practice team members for an immersive, multi-day program built around the theme “Beyond Possible.” The event showcased how innovation and connected digital workflows are expanding what can be achieved in orthodontic care with solutions designed to help doctors visualize, plan, and treat with greater confidence and predictability using the Invisalign® System.

The event also celebrated the orthodontists and practices who have helped expand the possibilities of Invisalign treatment through their expertise, innovation, and commitment to creating healthy, confident smiles for their patients for nearly 30 years.

Attendees explored how Align’s integrated portfolio across the Align™ Digital Platform, including the Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software is helping doctors transform cases once considered complex into more predictable, efficient, and routine Invisalign treatment.

“Doctors don’t just want another product, they want a connected experience that works the way their practice actually runs,” said Frank Quinn, Align Technology executive vice president and managing director, Americas. “That’s what ‘Beyond Possible’ is about. When the workflow comes together from scan to plan to treatment and beyond, it gives doctors more time to focus on patients and deliver great outcomes.”

An Innovation Hub Built for Hands-On Discovery

At the center of the Summit was the Align Innovation Hub, an immersive, hands-on environment where doctors explored digital workflows, technologies, and solutions through interactive stations and guided experiences.

“The innovations unveiled at Summit were remarkable. Align Technology’s commitment to continually raising the bar and pushing the boundaries of what’s possible in orthodontics is inspiring,” said Dr. Erin Fraundorf, D.M.D., M.S.D, Artist Behind the Smiles and Founder of BOCA Orthodontic + Whitening Studio, Ladue, MO.

She continued, “What impresses me even more, though, is how much they listen to their doctors. They genuinely value our feedback and continuously evolve their technology based on what we need in practice, giving us more options, greater precision, and more control over treatment. That ultimately allows us to deliver an even better patient experience and achieve exceptional clinical outcomes.”

Anchored by dedicated experiences for the iTero Lumina™ intraoral scanner, the Hub featured five focused areas of concentration for discovery, engagement, and connection:

  • Invisalign for Kids – Showcasing how early intervention is being transformed through digital innovation, including how Invisalign First™, the Invisalign® Palatal Expander System (IPE), and the digital workflow build confidence in interceptive care and complex growing-patient cases.
  • Treatment Planning – Live, 1:1 clinical support to review ClinCheck® Signature Experience preferences, including updates to the Invisalign Personalized Plan (IPP), so doctors could see treatment planning happen in minutes and with fewer modifications.
  • In-Face Visualization – New features on Invisalign® Outcome Simulator Pro (IOSim Pro) and ClinCheck® software with 3D Tissue Animation, giving doctors more compelling ways to help patients see and understand what treatment can do.
  • Flexible Portfolio – A deep dive into how Align delivers more predictable, efficient outcomes by giving doctors greater control and confidence in treatment planning and execution through the comprehensive Invisalign portfolio.
  • Innovators Behind the Smile Studio – An interactive content-creation studio where doctors could create and record user-generated content while exploring best-practice creator tools for engaging today’s patients.

Eight additional areas highlighted next-generation digital orthodontics, including Align Innovations, Accessories, the Advantage Program, and Business Development & Practice Marketing.

Within the Hub, Align showcased a robust set of innovations designed to improve consistency, precision, and efficiency across clinical workflows:

  • The Invisalign Specifix™ Attachment System, currently available in select locations through a limited market release, is a 3D-printed attachment solution that combines attachments 3D-printed to the exact shape and size indicated in the doctor’s treatment plan with a novel bonding accessory for precise placement.1 The Specifix system is designed to reduce variability in attachment size and placement, increase consistency, and streamline the attachment workflow.
  • Invisalign® integrated buttons – a new digital approach to the small, bonded accessories used to anchor elastics and apply targeted forces during treatment. Digitally integrated buttons incorporate button planning into the ClinCheck® treatment planning workflow, replacing the standard manual process. With this digital approach, button type and position are determined within the software during treatment planning and doctors can modify as needed, helping to reduce chairside guesswork, improve placement accuracy, and deliver a more flexible, precise, and efficient bite correction.
  • Invisalign® Palatal Expander System with integrated hook features – a further evolution of Align’s 3D-printed palatal expander system designed to help doctors treat a broader range of patients with added flexibility. Building on the clinically effective2 Invisalign® Palatal Expander (IPE) System, the new forward- and backward-facing integrated hooks are compatible with elastics3, offering intuitive enhancements to palatal expansion with Class III or Class II treatments.
  • Invisalign clear aligner custom trimline option gives doctors greater control over aligner gingival margins to support versatility with aesthetics, comfort, and clinical flexibility. In cases where doctors feel there is insufficient retention, they can consider an extended scalloped trimline for short clinical crowns, erupting dentition cases, preferences for fewer attachments, extended tooth coverage in gingival recession and in extending to include the undercut of the clinical crowns. Integrated directly into the ClinCheck® digital treatment planning workflow, custom trim lines allow doctors to personalize aligner design based on individual patient anatomy and treatment needs.
  • New features in Invisalign® Outcome Simulator Pro is anext-generation in-face simulation tool that allows patients to see potential treatment outcomes with realistic visualizations, including arch control and bite contact Occlusogramfor improved engagement.
  • 3D Tissue Animation is anew ClinCheck® feature designed to simulate how a patient’s facial soft tissue may change by the end of treatment, supporting aesthetic-focused planning and more personalized patient conversations.

Orthodontist-Led Sessions and Real-World Case Sharing

The Summit program featured orthodontist-led sessions covering complex cases, digital workflow optimization, and patient engagement strategies. Interactive formats including panels, breakout sessions, and live demonstrations that encouraged open dialogue and practical knowledge sharing.

Sessions highlighted how doctors are applying digital tools to treat a broader range of cases with greater confidence, while also driving efficiency and growth in their practices.

“The Invisalign Ortho Summit in Las Vegas left me energized about where Align Technology is taking orthodontics, particularly the advances in visualization, diagnostics, and direct 3D printing,” said Dr. David Walt, D.D.S., MSD., Walt Orthodontics, Vaughan, ON. “Learning alongside my peers reinforced the clinical excellence we can achieve with the Invisalign Palatal Expander and Invisalign First. I was equally grateful for the chance to share how I leveraged the Align Digital Platform to optimize practice efficiency and the patient experience.”

Advancing “Beyond Possible”: Investments Across the Align Digital Platform

The 2026 Invisalign Ortho Summit reflects Align’s broader strategy to move beyond individual products and toward a connected experience that supports prevention, early intervention, and digitally driven care delivery. Ongoing investments in the Align™ Digital Platform continue to unify scanning, visualization, treatment planning, manufacturing, monitoring, retention, and now practice-management connectivity into a single, cohesive ecosystem for doctors and patients. Focus areas showcased at the Summit included:

  • Advancing digital orthodontic workflows that connect intraoral scanning, digital treatment planning, aligner fabrication, monitoring, and retention into seamless, data-driven experiences for doctors and patients.
  • Continued leadership in digital manufacturing and 3D printing, enabling consistent, high-quality Invisalign aligner production at global scale while supporting speed and reliability for orthodontic practices.
  • Ongoing investment in automation, designed to help doctors work more efficiently while maintaining clinical oversight and control as case complexity and practice scale increase.
  • Expansion of diagnostic and visualization capabilities, supporting earlier intervention, improved patient understanding, and more confident treatment planning across a broader range of malocclusions and growth patterns.
  • Scaling of integrated solutions, reflecting growing adoption of digitally connected orthodontic workflows in diverse practice models.
  • Independent validation of the Invisalign® Palatal Expander System (IPE) – A clinical study by researchers at the University of Insubria, Italy found that the Invisalign® Palatal Expander System was shown to effectively widen the upper jaw by opening the natural growth seam in the palate, achieving bone and bite changes similar to a traditional metal Hyrax expander. IPE also delivered more controlled and predictable results than Hyrax, supporting its use as a reliable option for growing patients and highlighting its role as a key step toward fully digital orthodontic care4.

“Events like the Invisalign Ortho Summit show what’s possible when innovation and real-world experience come together,” Quinn added. “For nearly 30 years, doctors have used our tools and technology to create 23 million new smiles for their patients. As we continue to build a more connected experience, we’re focused on helping doctors go beyond what was once thought possible both in how they treat patients and how they grow their practices.”

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 302.0 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 29 years, Align has helped doctors treat approximately 23.5 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.

* The availability of products may vary by market and is subject to applicable regulatory approvals and clearances. Please check with your local Align team for further information.

  1. Based on bench testing conducted in August 2025 according to Design Verification on Specifix™ attachment volume precision (A035851). Data on File at Align Technology, as of January 28, 2026.

  2. Based on data from a multi-site US IDE (Investigational Device Exemption) clinical study (n=29 subjects, ages 7-10 years) of expansion treatment with Invisalign® Palatal Expanders. Data on file at Align Technology, as of October 30, 2023

  3. Elastics are not supplied/provided by Align Technology, Inc

  4. Levrini L, Saran S, Imbesi E, Vanini I, Russo V, Rimoldi V, Carganico A, Giannotta N and Perugini M (2026), Skeletal and dentoalveolar effects on the midpalatal suture and maxillary arch assessed by occlusal radiographs and three-dimensional digital models in patients treated with invisalign palatal expander and rapid palatal expander: a pilot study. Front. Dent. Med. 7:1757094. doi: 10.3389/fdmed.2026.1757094

 

Align Technology, Inc.

Madelyn Valente

(909) 833-5839

[email protected]

Zeno Group

Sarah Johnson

(828) 551-4201

[email protected]

KEYWORDS: Nevada Arizona United States North America

INDUSTRY KEYWORDS: Health Dental Medical Devices

MEDIA:

Logo
Logo
Posted on

Accuray Announces Plan Involving Financial Strengthening, Strategic Partnerships, Technology Rollouts, and Operational Initiatives to Drive Long-Term Value Creation

PR Newswire

MADISON, Wis., July 29, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, today announced a plan incorporating several decisive actions that will drive a significant improvement in its financial position, a fundamental change in its business strategy, the rollout of differentiated technology, and continued transformation in how the company operates. This enables a renewed focus on its core strengths in innovation, sales, and service while continuing to emphasize operational rigor.

Accuray Incorporated (PRNewsFoto/Accuray Incorporated) (PRNewsFoto/Accuray Incorporated)


Improved Financial Position

Accuray has entered into definitive agreements with TCW Asset Management Company LLC, Accuray’s primary lender and largest shareholder, that are intended to strengthen the company’s financial position, provide additional liquidity and enhance financial flexibility. The TCW agreements encompass six major components:

  • Deleveraging—TCW will exchange $40 million in aggregate principal amount of its term loan for shares of convertible preferred stock having an equivalent aggregate liquidation preference of $40 million. The convertible preferred stock will be convertible into common stock at a conversion price of $.50 per share, an approximately 105.4% premium to the trading price of Accuray’s common stock as of the close of trading yesterday and will accrue dividends at a rate of 8% per annum.
  • Equity Investment—TCW will invest $15 million of cash in Accuray upon execution of the agreements which will be exchanged for additional shares of the convertible preferred stock concurrently with the debt exchange.
  • Additional Liquidity—In addition to this cash investment, TCW has also agreed to make available to Accuray, subject to certain conditions, a delayed draw term loan of up to $5 million in aggregate principal amount.
  • Covenant Holiday—Certain financial covenants in our existing term loan will be waived through December 31, 2027, with the first covenant testing date as of March 31, 2028, allowing the company additional flexibility and runway to execute on its strategic priorities and planned investments.
  • Governance—The size of the company’s board of directors will be reduced from 8 to 7, with TCW having the right to appoint two directors of the 7 board members. Steven Mayer and Chan Galbato, current members of the board, will serve as designees for TCW. Concurrently with the execution of the agreements, Beverly Huss and Anne Le Grand stepped down from the board. A new independent director will be added in connection with the transaction.
  • Reverse Stock Split—Accuray has agreed to implement a reverse stock split applicable to its common shares in a ratio to be determined.

“The agreements with TCW provide us with increased financial flexibility and a stronger balance sheet, which will in turn allow us to focus on our customers, our suppliers, and other important stakeholders,” said Steve La Neve, Accuray’s CEO. “We appreciate TCW’s confidence in our business plan and our strategy that we had articulated last December. Our entire team is determined to reward that confidence by creating significant shareholder value going forward.”

A more detailed description of the transaction with TCW is included in Accuray’s Current Report on Form 8-K and will be filed with the Securities and Exchange Commission. Investors are encouraged to review the Form 8-K for additional information regarding the terms and conditions of the transaction and related agreements. Certain aspects of the above transactions remain subject to customary closing conditions, including stockholder approval of the proposed reverse stock split and certain equity issuances contemplated by the transaction.


Strategic Partnerships to Improve Performance and Accelerate Innovation

In order to enhance Accuray’s capabilities across imaging, software, and treatment delivery, while enabling greater focus on its core strengths, Accuray intends to establish collaborations with several leading global technology organizations. These partnerships are designed to accelerate innovation, improve operational performance, and create greater value for customers, patients, and shareholders. For example, Accuray has recently entered into the following non-binding letters of intent (“LOIs”):

  • Samsung HME America—Accuray has entered into a non-binding LOI with Samsung HME America, Inc., dba NeuroLogica Corp. This potential partnership would address volumetric imaging technologies and would enable Accuray’s radiation therapy systems to provide improved visualization and support more precise dose delivery.
  • RaySearch Laboratories—Accuray has entered into a non-binding LOI with RaySearch Laboratories AB (publ) relating to the development of advanced adaptive radiation therapy through integrated online adaptive capabilities. This potential partnership would support more personalized treatment planning.

Both above-mentioned LOIs are nonbinding, and the scope, terms and benefits of any proposed collaboration remain subject to further negotiations and the execution of definitive agreements.

In addition, under a previously agreed partnership, Accuray and Tata Consultancy Services (TCS) continue to expand their collaboration to improve product development, service capabilities, and operational efficiency. Most recently, the companies finalized development of onboard remote diagnostics designed to enhance system performance, increase uptime, and enable more proactive service capabilities, benefiting customers, patients, and Accuray’s service margins. Building on this foundation, Accuray is continuing to leverage TCS’s engineering expertise to augment research and development activities, accelerate innovation, and support ongoing efforts to reduce costs while maintaining a strong focus on quality and customer outcomes.

Together, these partnerships are intended to help accelerate the delivery of innovative solutions that improve clinical efficiency, expand treatment capabilities, and support better outcomes for patients around the world, while simultaneously allowing Accuray to focus its energy and resources on its core competencies and to drive improved operational execution across the organization. “We are excited to partner with these world class companies that will help us move faster, innovate more effectively, and deliver greater value to our customers,” said Paul Miele, Chief Commercial Officer. “We are building an ecosystem that strengthens every part of our platform.”


Differentiated Internally Developed Technology

Concurrently with the above steps, Accuray has continued to invest in and expand its core technology differentiators, including:

  • ClearRT® Helical kVCT Imaging—Accuray’s advanced volumetric imaging technology is designed to provide high-quality visualization and anatomical detail for treatment planning, patient positioning, and adaptive workflows, helping clinicians make more informed decisions throughout the treatment process.
  • Synchrony® Motion Management—Accuray’s proprietary, internally developed real-time motion tracking technology remains a key differentiator, enabling clinicians to accurately track tumor motion during treatment.
  • VOLO™ Optimizer & Software Platform—Ongoing enhancements and engineering partnerships are focused on improving treatment planning speed, precision, and usability.

Accuray has been rolling out these innovations across its installed base of customers and intends to accelerate expansion in the coming months.


Transformation Phase II – A Focused and Disciplined Path Forward

After designing and implementing the first phase of its transformation plan, which was primarily focused on efficiency and cost-competitiveness, Accuray is now entering the second phase of its transformation, which consists of decisive steps to strengthen its competitive position, enhance customer value, and drive long-term growth in revenues and margins. The company’s strategies are anchored in three distinct areas:

  • Differentiated Innovation—Advancing internally developed technologies and solutions that address evolving customer needs while improving treatment delivery.
  • Continuing to Lower Its Cost Structure—Simplifying operations, identifying and driving out inefficiencies, and leveraging strategic partnerships.
  • Expanded Market Reach—Strengthening direct and partner-based commercial channels to increase market penetration and improve customer engagement.

“We have improved our financial flexibility, increased operating discipline, and built a focused network of partnerships that accelerate innovation and execution,” said Steve La Neve. “We are leaning into what differentiates Accuray—precision, motion management, and intelligent software—to deliver better outcomes and greater value.”


Positioned for the Next Phase of Growth

Accuray believes that all of the coordinated actions described above position the company to deliver more consistent performance, better profitability, increased competitiveness, renewed growth, and long-term value creation.

“We are executing with focus and discipline,” said La Neve. “We are confident in our direction because it is grounded in the needs of our customers and their patients. By listening closely to their challenges and investing in the innovations that matter most, we are helping healthcare professionals deliver exceptional patient care and building long-term value for shareholders.”


About Accuray

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. For more information, please visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.


About TCW

TCW is a global asset management firm with more than fifty years of experience in fixed income, equities, and alternative strategies. Guided by a disciplined, research-driven approach, TCW concentrates on areas where deep expertise makes a meaningful difference. Through rigorous fundamental analysis, prudent risk management, and high-conviction decision-making, TCW strives to construct portfolios that uncover opportunities and deliver enduring value. TCW partners with institutions, insurers, financial advisors, and individual investors worldwide, providing clarity and a long-term perspective to help our clients navigate in ever-changing markets. For more information, please visit www.tcw.com. 


About Samsung Healthcare USA

Samsung Healthcare USA is the unified brand for Samsung HME (Healthcare and Medical Equipment) America, bringing advanced medical imaging solutions to healthcare providers across the United States, including Ultrasound, Digital Radiography, and Computed Tomography. Samsung HME America also serves as the global manufacturing center for Samsung’s mobile Computed Tomography business, leading the development and production of advanced CT systems used by healthcare providers worldwide. As part of the Samsung Healthcare family, Samsung HME America drives the sales, marketing, service, and support of Samsung Healthcare’s imaging solutions across the United States. For more information, please visit: https://usa.samsunghealthcare.com/.


About RaySearch

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation® treatment planning system and the oncology information system RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RaySearch’s software has been sold to over 1,200 clinics in 51 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.


About Tata Consultancy Services Ltd (TCS)

Tata Consultancy Services (BSE: 532540, NSE: TCS) is the technology partner of choice for industry-leading organizations worldwide. Since its inception in 1968, TCS has upheld the highest standards of innovation, engineering excellence and customer service.

It has set an aspiration to become the world’s largest AI-led technology services company and is enabling its clients to transform themselves across the full AI stack, from infrastructure to intelligence.

Rooted in the heritage of the Tata Group, TCS is focused on creating long term value for its clients, its investors, its employees, and the community at large. With a highly skilled workforce spread across 56 countries and 194 service delivery centers across the world, the company has been recognized as a top employer in six continents. With the ability to rapidly apply and scale new technologies, the company has built long term partnerships with its clients. Many of these relationships have endured into decades and navigated every technology cycle, from mainframes in the 1970s to artificial intelligence today. For more information, visit www.tcs.com


Safe Harbor Statement


Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include statements regarding the proposed transactions described above, including expected impact and timing of such transactions, as well as statements regarding our relationships with our customers and other stakeholders, our expectations regarding our transformation plan and our expectations of future financial and operating performance. These forward-looking statements involve risks and uncertainties. If any of these risks or uncertainties materialize, or if any of the company’s assumptions prove incorrect, actual results could differ materially from the results expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the company’s ability to satisfy the closing conditions with respect to its transaction with TCW and achieve the intended benefits of the transactions, the Company’s ability to consummate any of the potential commercial transactions described above, including those contemplated by the LOIs, the ability to achieve the benefits of such transactions, the company’s ability to execute on our financial plan and improve operating and financial performance, risks related to general market conditions and other risks identified under the heading “Risk Factors” in the company’s annual report on Form 10-K, filed with the Securities and Exchange Commission (the “SEC”) on August 28, 2025, and as updated periodically with the company’s other filings with the SEC.

Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management’s good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements.


Accuray Media Contact

Taylor Bould
Communications Specialist, Accuray
+1 (608) 830-3604
[email protected]


Samsung Healthcare USA Media Contact

Anthony Tardi
Samsung HME America
978.564.8500
[email protected] 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-announces-plan-involving-financial-strengthening-strategic-partnerships-technology-rollouts-and-operational-initiatives-to-drive-long-term-value-creation-302838357.html

SOURCE Accuray Incorporated

Posted on

Notice of Results

Diversified Energy Announces Timing of Second Quarter 2026 Results

BIRMINGHAM, Ala., July 29, 2026 (GLOBE NEWSWIRE) — Diversified Energy Company (NYSE: DEC, LSE: DEC) (“Diversified” or the “Company”) is pleased to announce that the Company plans to publish its operational and financial results for the quarter ended June 30, 2026 (the “second quarter results”) on Wednesday, August 5th, 2026, after the U.S. market close. The Company will host a conference call at 8:30 AM EST (1:30 PM GMT) on Thursday, August 6th to discuss the second quarter 2026 results and make an audio replay of the event available shortly thereafter.

Conference Details    
US (toll-free) +1 877-836-0271 / +1 201-689-7805
UK (toll-free) + 44 (0) 800 756 3429
Web Audio
https://www.div.energy/news-events/ir-calendarevents
Replay Information
https://ir.div.energy/financial-info


Prior to the event, Diversified will publish the Company’s second quarter results on its website at https://ir.div.energy/financial-info and also make available a supplementary second quarter results Presentation at https://ir.div.energy/presentations.

For further information, please contact:

Diversified Energy Company +1 973 856 2757
Doug Kris [email protected]
Senior Vice President, Investor Relations &
Corporate Communications		 www.div.energy
   
FTI Consulting [email protected]
U.S. & UK Financial Public Relations  



About Diversified Energy Company

Diversified is a leading publicly traded energy company focused on acquiring, operating, and optimizing cash-generating energy assets. Through our unique differentiated strategy, we acquire existing, long-life assets and invest in them to improve environmental and operational performance until retiring those assets in a safe and environmentally secure manner. Recognized by ratings agencies and organizations for our sustainability leadership, this solutions-oriented, stewardship approach makes Diversified the Right Company at the Right Time to responsibly produce energy, deliver reliable free cash flow, and generate shareholder value.



Posted on

General Dynamics Electric Boat awarded construction contracts for 14 submarines as part of $76.6 billion Navy award

PR Newswire

GROTON, Conn., July 29, 2026 /PRNewswire/ — As part of today’s $76.6 billion Navy contract announcement, General Dynamics Electric Boat, a business unit of General Dynamics (NYSE: GD), announced it has been awarded $29.5 billion for five additional Columbia-class submarines, $42.1 billion for nine additional Virginia-Class submarines, and additional support for shipyard infrastructure.

General Dynamics Electric Boat designs, builds, repairs and modernizes nuclear submarines for the U.S. Navy.

Information about these contract modifications is detailed in the U.S. Department of War contract awards, which can be found here and here.

“These important contract modifications provide Electric Boat and our suppliers with the demand certainty we need to continue investing in capacity and hiring the workforce necessary to ensure we deliver these important national security assets on schedule,” said Mark Rayha, president of General Dynamics Electric Boat.

General Dynamics Electric Boat designs, builds, repairs and modernizes nuclear submarines for the U.S. Navy. Headquartered in Groton, Connecticut, it employs more than 27,000 people. More information about General Dynamics Electric Boat is available at www.gdeb.com.

Headquartered in Reston, Virginia, General Dynamics is a global aerospace and defense company that offers a broad portfolio of products and services in business aviation; ship construction and repair; land combat vehicles, weapons systems and munitions; and technology products and services. General Dynamics employs more than 120,000 people worldwide and generated $52.6 billion in revenue in 2025. More information is available at www.gd.com.

General Dynamics (PRNewsFoto/General Dynamics) (PRNewsFoto/General Dynamics)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/general-dynamics-electric-boat-awarded-construction-contracts-for-14-submarines-as-part-of-76-6-billion-navy-award-302838350.html

SOURCE General Dynamics

Posted on

Wetour Robotics Announces Share Consolidation

AUSTIN, Texas, July 29, 2026 (GLOBE NEWSWIRE) — Wetour Robotics Limited (Nasdaq: WETO) (“Wetour Robotics” or the “Company”), a Physical AI infrastructure and wearable robotics company, today announced that it will effect a share consolidation of its ordinary shares of par value US$0.0001 each at a ratio of 1-for-100, effective on August 3, 2026 (the “Share Consolidation”). The Company’s ordinary shares are expected to begin trading on a post-consolidation basis at the open of the market session on August 3, 2026. Upon the market opening on August 3, 2026, the Company’s ordinary shares will continue to be traded on The Nasdaq Stock Market under the symbol “WETO” with the new CUSIP number G9513A119.

Prior to the Share Consolidation, 107,783,305 ordinary shares are issued and outstanding. As a result of the Share Consolidation, every 100 shares (or part thereof) will be combined into one (1) share, with fractional shares rounded up to the next whole share, and approximately 1,077,834 ordinary shares will be issued and outstanding after the Share Consolidation. The Company is authorized to issue 10,000,000 number of ordinary shares of par value US$0.01 each. All outstanding stock options, warrants and other rights to purchase the Company’s ordinary shares will be adjusted proportionately as a result of the Share Consolidation.

Upon the effectuation of the Share Consolidation, shareholders holding shares through a bank, broker or other nominee will have their shares automatically adjusted to reflect the Share Consolidation. Beneficial holders may contact their bank, broker or nominee for more information. Please direct any questions to your broker or the Company’s transfer agent, VStock Transfer, LLC, by calling +1 (212) 828-8436.

About Wetour Robotics Limited

Wetour Robotics Limited (NASDAQ: WETO) is a Physical AI infrastructure and wearable robotics company headquartered in Austin, Texas. The Company is developing Orchestra, a Physical AI platform that connects intelligent agents to the physical world through wearable sensors, visual intelligence, edge AI computing and connected machines. Conductor is the Company’s wrist-worn neuromuscular interface, and VisionLink is its visual intelligence module.

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans for future business development, including its financial conditions and results of operations, product and service demand and acceptance, reputation and brand, the impact of competition and pricing, changes in technology, government regulations, fluctuations in general economic and business conditions, the Company’s ability to comply with Nasdaq continued listing standards and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

Investor Relations Contact

Annabelle Li
Head of Investor Relations
[email protected]



Posted on

MercadoLibre, Inc. to Report Second Quarter 2026 Financial Results

MercadoLibre, Inc. to Report Second Quarter 2026 Financial Results

MONTEVIDEO, Uruguay–(BUSINESS WIRE)–
MercadoLibre, Inc. (Nasdaq: MELI) (http://www.mercadolibre.com) announces that it intends to release financial results for its second fiscal quarter ending June 30, 2026, on August 5, 2026.

The Company will host its earnings results video conference, as well as a conference call and audio webcast, on August 5, at 5:00 p.m. Eastern Time.

In order to access our video webcast and the live audio, investors, analysts and the market in general may access the following link at https://event.choruscall.com/hmediaframe/webcast.html?webcastid=xr1sGkCu to attend the live event.

To participate in our conference call Q&A, investors, analysts and the market in general may access the following link https://hdr.choruscall.com/?$Y2FsbHR5cGU9MiZyPXRydWUmaW5mbz1jb21wYW55LXBob25l or dial in through the following numbers: TOLL FREE 1-833-821-3654 | INTERNATIONAL 1-412-652-1249 and ask to join MercadoLibre’s conference call to be able to pose questions.

Access to our video webcast and the live audio will be available in the investor relations section of the Company’s website, at http://investor.mercadolibre.com. An archive of the webcast will be available for one week following the conclusion of the conference call.

About MercadoLibre

MercadoLibre is the largest online commerce ecosystem in Latin America, based on unique visitors and processed orders, and is also one of the region’s leading fintech platforms. Our efforts are centered on enabling e-commerce and digital financial services for our users by delivering a complete suite of technology solutions. The company is present in 18 countries including: Argentina, Brazil, Mexico, Colombia, Chile, Ecuador and Peru.

Through its e-commerce platform, MercadoLibre provides buyers and sellers with a robust and safe environment that fosters the development of a large e-commerce community in Latin America, a region with a population of over 650 million people and with one of the fastest-growing Internet penetration and e-commerce growth rates in the world. We believe that we offer world-class technological and commercial solutions that address the distinctive cultural and geographic challenges of operating a digital commerce platform in Latin America.

Through its fintech platform, MercadoPago, the company offers a comprehensive set of financial technology services to users of its e-commerce platform, and to users outside of its e-commerce platform. For individuals, those services include a digital account that offers a debit card, online payments, insurance, savings, investments and credit lines. For merchants, MercadoPago offers online and physical point-of-sale payments processing services as well as the digital account. For more information about MercadoLibre.com, visit: http://investor.mercadolibre.com.

Investor Relations Contact:

[email protected]
http://investor.mercadolibre.com

Media Relations Contact:

[email protected]

KEYWORDS: New York Latin America North America United States South America Uruguay

INDUSTRY KEYWORDS: Professional Services Payments Technology Finance Electronic Commerce Fintech Internet

MEDIA:

Posted on

HIMS INVESTOR ALERT: Investigation of Hims & Hers Health, Inc. Announced by Holzer & Holzer, LLC

ATLANTA, July 29, 2026 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS) complied with federal securities laws. On July 29, 2026, the Federal Trade Commission (“FTC”) announced that it is suing Hims & Hers alleging the Company “fails to clearly disclose that it charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is ‘right for them.’” Following this news, the price of the Company’s stock dropped. 

If you purchased Hims & Hers stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/hims-hers-health/ to discuss your legal rights.  

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

CONTACT:  
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]



Posted on

Capital One Announces Quarterly Dividend

Capital One Announces Quarterly Dividend

Company also declares preferred stock dividend

MCLEAN, Va.–(BUSINESS WIRE)–
Capital One Financial Corporation (NYSE: COF) today announced a quarterly dividend of $0.80 per common share payable September 1, 2026, to stockholders of record at the close of business on August 17, 2026. The company has announced dividends on its common stock every quarter since it became an independent company on February 28, 1995. Dividends declared by the company are eligible for direct reinvestment in the company’s common stock under its Dividend Reinvestment and Stock Purchase Plan. For additional Plan information, stockholders should contact Computershare Trust Company, N.A., at 1-888-985-2057 (inside the U.S. and Canada) or 1-781-575-2725 (outside the U.S. and Canada).

The company also declared a quarterly dividend on the outstanding shares of its 5.00 percent Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series I (the “Series I Preferred Stock”). Each outstanding share of the Series I Preferred Stock is represented by depositary shares, each representing a 1/40th interest in a share of Series I Preferred Stock. The dividend of $12.50 per share (equivalent to $0.3125 per outstanding depositary share) will be paid on September 1, 2026, to stockholders of record at the close of business on August 17, 2026.

The company also declared a quarterly dividend on the outstanding shares of its 4.80 percent Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series J (the “Series J Preferred Stock”). Each outstanding share of the Series J Preferred Stock is represented by depositary shares, each representing a 1/40th interest in a share of Series J Preferred Stock. The dividend of $12.00 per share (equivalent to $0.30 per outstanding depositary share) will be paid on September 1, 2026, to stockholders of record at the close of business on August 17, 2026.

The company also declared a quarterly dividend on the outstanding shares of its 4.625 percent Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series K (the “Series K Preferred Stock”). Each outstanding share of the Series K Preferred Stock is represented by depositary shares, each representing a 1/40th interest in a share of Series K Preferred Stock. The dividend of $11.5625 per share (equivalent to $0.2890625 per outstanding depositary share) will be paid on September 1, 2026, to stockholders of record at the close of business on August 17, 2026.

The company also declared a quarterly dividend on the outstanding shares of its 4.375 percent Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series L (the “Series L Preferred Stock”). Each outstanding share of the Series L Preferred Stock is represented by depositary shares, each representing a 1/40th interest in a share of Series L Preferred Stock. The dividend of $10.9375 per share (equivalent to $0.2734375 per outstanding depositary share) will be paid on September 1, 2026, to stockholders of record at the close of business on August 17, 2026.

The company also declared a quarterly dividend on the outstanding shares of its Fixed Rate Reset Non-Cumulative Perpetual Preferred Stock, Series M (the “Series M Preferred Stock”). The dividend of $9.875 per share will be paid on September 1, 2026, to stockholders of record at the close of business on August 17, 2026.

The company also declared a quarterly dividend on the outstanding shares of its 4.25 percent Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series N (the “Series N Preferred Stock”). Each outstanding share of the Series N Preferred Stock is represented by depositary shares, each representing a 1/40th interest in a share of Series N Preferred Stock. The dividend of $10.625 per share (equivalent to $0.265625 per outstanding depositary share) will be paid on September 1, 2026, to stockholders of record at the close of business on August 17, 2026.

The company also declared a semiannual dividend on the outstanding shares of its Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series O (the “Series O Preferred Stock”). Each outstanding share of the Series O Preferred Stock is represented by depositary shares, each representing a 1/100th interest in a share of the Series O Preferred Stock. The dividend of $2,750 per share (equivalent to $27.50 per outstanding depositary share) will be paid on October 30, 2026, to stockholders of record at the close of business on October 15, 2026.

About Capital One

Capital One Financial Corporation (NYSE: COF) is a leading technology-based financial services company with $484.3 billion in deposits and $673.8 billion in total assets as of June 30, 2026. Headquartered in McLean, Virginia, the company operates as a premier global payments provider and diversified financial institution, delivering a broad suite of products and consumer lifestyle and shopping experiences through its Credit Card, Consumer Banking including its Global Payment Network, and Commercial Banking lines of business. As the only major U.S. bank to migrate entirely to the public cloud, Capital One leverages proprietary data and advanced analytics to democratize financial tools across its primary markets in the United States, Canada, and the United Kingdom

Jonathan Black

[email protected]

KEYWORDS: Virginia United States North America

INDUSTRY KEYWORDS: Professional Services Payments Technology Finance Fintech Banking

MEDIA:

Logo
Logo
Posted on

Essential Utilities Announces Dividend Increase

Essential Utilities Announces Dividend Increase

BRYN MAWR, Pa.–(BUSINESS WIRE)–
The board of directors of Essential Utilities, Inc. (NYSE: WTRG) today declared a quarterly cash dividend of $0.3606 per share, an increase of 5.25%, payable September 1, 2026, to all shareholders of record on August 11, 2026.

Essential Utilities has paid consecutive quarterly cash dividends for over 80 years and has increased the dividend 36 times in the last 35 years.

About Essential

Essential Utilities, Inc. (NYSE: WTRG) delivers safe, clean, reliable services that improve quality of life for individuals, families, and entire communities. With a focus on water, wastewater and natural gas, Essential is committed to sustainable growth, operational excellence, a superior customer experience, and premier employer status. We are advocates for the communities we serve and are dedicated stewards of natural lands, protecting thousands of acres of forests and other habitats throughout our footprint.

Operating as the Aqua and Peoples brands, Essential serves approximately 5.5 million people across nine states. Essential is one of the most significant publicly traded water, wastewater service and natural gas providers in the U.S. Learn more at www.essential.co.

WTRGF

Media:

David Kralle

Vice President of Public Affairs

Media Hotline: 1.877.325.3477

[email protected]

Investor:

Brian Dingerdissen

Vice President, Treasurer, FP&A and IR

O: 610.645.1191

[email protected]

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Oil/Gas Natural Resources Energy Other Natural Resources Utilities

MEDIA:

Logo
Logo
Posted on

Willamette Valley Vineyards Wins #1 Best Tasting Room in the Nation in USA Today 10Best Readers’ Choice Awards for Third Consecutive Year

PR Newswire

The winery becomes the first three-time consecutive winner of the #1 ranking as readers also name its wine club #1 in the nation 

SALEM HILLS, Ore., July 29, 2026 /PRNewswire/ — Willamette Valley Vineyards (NASDAQ: WVVI, WVVIP) has once again been recognized by wine enthusiasts nationwide, earning the #1 Best Wine Tasting Room ranking in the USA TODAY 10 Best Readers’ Choice Awards for the third consecutive year. In a historic first for the winery, readers also named the Willamette Valley Vineyards Wine Club the #1 Best Wine Club in the nation.

Willamette Valley Vineyards Founder and President Jim Bernau celebrates with the winery team following Wednesday's announcement that the winery was named USA Today's #1 Best Wine Tasting Room for the third time.

This recognition reflects the strong support of shareholders and club members, and highlights the winery’s commitment to delivering exceptional hospitality and memorable culinary experiences alongside world-class Oregon wines. Additionally, the winery’s innovative Club Willamette subscription-style wine club is a defining aspect of this year’s Best Wine Club honor.

Set against panoramic vineyard views, the Estate Tasting Room invites visitors to experience its award-winning wines, locally sourced cuisine, tours and special events planned throughout the year. An expansive patio, spacious courtyard, cozy fireplaces and a 65-foot lookout tower help round out the experience.

“Earning recognition as the #1 tasting room after being honored for three consecutive years is especially meaningful because it reflects the dedication of our team, shareholders and wine club members,” said Mike Osborn, CEO of Willamette Valley Vineyards. “To celebrate not only our tasting room, but also our first-ever #1 wine club win is a testament to the community we’ve built together and the unforgettable experiences we strive to create every day.”

Complementing the tasting room’s top honor, the winery’s Wine Club earned its first-ever #1 ranking in the USA TODAY 10Best Readers’ Choice Awards. Willamette offers 14 membership tiers, including Club Willamette, a unique monthly subscription model that gives members the flexibility to choose which wines they receive and when. Benefits include 20% off wine club selections and bottled wines, access to library and pre-release wines, complimentary tours and tastings and invitations to exclusive events.

The winery is further distinguished by its community-ownership model, which includes more than 27,000 shareholders committed to preserving Oregon wine for future generations. With tasting rooms located throughout Oregon, Washington and California, Willamette Valley Vineyards continues to set the standard for immersive wine and culinary experiences in Oregon and beyond.

Willamette Valley Vineyards was joined on the top 10 list of Best Wine Tasting Rooms by two other wineries in Oregon: Brooks Wine at #6 and Stoller Family Estate at #7, making an impactful showing for Oregon wine in this annual competition.

For more information on Willamette Valley Vineyards, visit www.wvv.com.

About Willamette Valley Vineyards

Founded in 1983 by President Jim Bernau with the dream of creating world-class Pinot Noir while serving as stewards of the land, Willamette Valley Vineyards has grown from a bold idea into one of the region’s leading wineries, earning the title “One of America’s Great Pinot Noir Producers” from Wine Enthusiast magazine. In addition, all the vineyards have been certified sustainable through LIVE and Salmon-Safe programs. With 1,000 acres under vine, Willamette farms its Estate winery in the Salem Hills, sparkling winery Domaine Willamette in the Dundee Hills, pioneering Tualatin Estate Vineyard near Forest Grove and Elton Vineyard in the Eola-Amity Hills. The winery has expanded recently to include nine tasting rooms in Oregon, Washington and California – growth made possible by the stock ownership of many wine enthusiasts.

Press Contacts:
Courtney Conte
[email protected]
Colangelo & Partners

Willamette Valley Vineayrds

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/willamette-valley-vineyards-wins-1-best-tasting-room-in-the-nation-in-usa-today-10best-readers-choice-awards-for-third-consecutive-year-302838321.html

SOURCE Willamette Valley Vineyards